PWM
CELG

PRW Wealth Management’s Celgene Corp CELG Stock Holding History

PRW Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-142
Closed -$14K – 794
2019
Q1 		$14K Hold
142
– – 0.01% 254
2018
Q4 		$10K Buy
+142
New +$10.5K 0.01% 293

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

PRW Wealth Management's CELG Position: Q2 2019 in Review

PRW Wealth Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 142 shares — an estimated $14K sold.

PRW Wealth Management first reported a position in CELG in Q4 2018 and held it in 2 quarters. The position peaked at $14K in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • PRW Wealth Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • PRW Wealth Management sold 142 Celgene Corp shares in Q2 2019, an estimated $14K.
  • PRW Wealth Management first reported a position in Celgene Corp in Q4 2018 and held it in 2 quarters.
  • PRW Wealth Management's Celgene Corp position peaked at $14K in Q1 2019.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on PRW Wealth Management's 13F filing for Q2 2019, filed 12 Aug 2019.